Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cephalalgia : an International Journal of Headache
|
February 14, 2023
Hypnic Headache - What do we know in 2022?
Diana Lindner, Armin Scheffler, Michael Nsaka, et al.
The Journal of Headache and Pain
|
May 10, 2022
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study
Hannah Schenk, Dagny Holle, Michael Nsaka, et al.
The Journal of Headache and Pain
|
July 5, 2020
Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
Armin Scheffler, Olga Messel, Sebastian Wurthmann, et al.
The Journal of Headache and Pain
|
September 21, 2021
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Armin Scheffler, Hannah Schenk, Sebastian Wurthmann, et al.
Brain and Behavior
|
June 10, 2022
Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodies
Michael Nsaka, Armin Scheffler, Sebastian Wurthmann, et al.
European Journal of Neurology
|
August 11, 2021
Response to the Letter to the Editor by Arshad and Bronstein "Motion perception in vestibular migraine"
Sebastian Wurthmann, Steffen Naegel, Michael Nsaka, et al.
European Journal of Neurology
|
April 29, 2021
Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: A cross-sectional study
Sebastian Wurthmann, Steffen Naegel, Miriam Roesner, et al.
BMC Neurology
|
October 13, 2021
Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional study
Sebastian Wurthmann, Dagny Holle, Mark Obermann, et al.
The Journal of Headache and Pain
|
July 4, 2024
Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis
Armin Scheffler, Jale Basten, Lennart Menzel, et al.
The Journal of Headache and Pain
|
May 16, 2024
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany
Armin Scheffler, Pauline Wenzel, Merle Bendig, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cephalalgia : an International Journal of Headache
|
February 14, 2023
Hypnic Headache - What do we know in 2022?
Diana Lindner, Armin Scheffler, Michael Nsaka, et al.
The Journal of Headache and Pain
|
May 10, 2022
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study
Hannah Schenk, Dagny Holle, Michael Nsaka, et al.
The Journal of Headache and Pain
|
July 5, 2020
Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
Armin Scheffler, Olga Messel, Sebastian Wurthmann, et al.
The Journal of Headache and Pain
|
September 21, 2021
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Armin Scheffler, Hannah Schenk, Sebastian Wurthmann, et al.
Brain and Behavior
|
June 10, 2022
Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodies
Michael Nsaka, Armin Scheffler, Sebastian Wurthmann, et al.
European Journal of Neurology
|
August 11, 2021
Response to the Letter to the Editor by Arshad and Bronstein "Motion perception in vestibular migraine"
Sebastian Wurthmann, Steffen Naegel, Michael Nsaka, et al.
European Journal of Neurology
|
April 29, 2021
Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: A cross-sectional study
Sebastian Wurthmann, Steffen Naegel, Miriam Roesner, et al.
BMC Neurology
|
October 13, 2021
Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional study
Sebastian Wurthmann, Dagny Holle, Mark Obermann, et al.
The Journal of Headache and Pain
|
July 4, 2024
Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis
Armin Scheffler, Jale Basten, Lennart Menzel, et al.
The Journal of Headache and Pain
|
May 16, 2024
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from Germany
Armin Scheffler, Pauline Wenzel, Merle Bendig, et al.
Page
of 1